Changing the conversation regarding pediatric cholesterol screening: The rare disease paradigm

摘要

The rhetoric supporting widespread pediatric lipid screening, as well as screening for other cardiovascular disease risk factors in youth, typically begins with recounting the burden of cardiovascular disease in our society. It is the number one killer in the United States and will soon be so throughout the world. We need to prevent it, beginning in childhood when the atherosclerotic process starts.